Table 1.
The clinical characteristic of patient groups
| Parameter/patient group | Asthma (n = 27) | Healthy control (n = 22) |
|---|---|---|
| Age (years) | 12.6 ± 3.4 | 12.4 ± 4.9 |
| Sex distribution (female/male) | 11/16 | 10/12 |
| Polysensitized patients | 22a | 0 |
| Monosensitized patient | 5a | 0 |
| Including patients sensitized to: | ||
| Grass | 23 | 0 |
| Mites | 22 | 0 |
| Animals | 15 | 0 |
| Alternaria | 5 | 0 |
| Cladosporium | 3 | 0 |
| FEV1SDS | 0.5 ± 0.2 | 0.3 ± 0.2 |
| FEV1/FVCSDS | −0.3 ± 0.2 | −1.1 ± 0.5 |
| Exhaled NO (ppb) | 27.2 ± 14.3a | 12.8 ± 5.3 |
| Blood eosinophils (×103/μl) | 0.31 ± 0.1 | 0.18 ± 0.1 |
| Total IgE serum level (kU/l) | 1,302 ± 758a | 33.2 ± 9.8 |
Mean values ± SD
FEV1 forced expiratory volume in the first second, FVC forced vital capacity, FEV1/FVC Tiffeneau–Pinelli index, SDS standard deviation score (Z-score), − value corrected in relation to the age
aStatistically significant, as compared to control group